Register
Login:
Share:
Email Facebook Twitter


EXCLUSIVE: Petro Metad go for broke with 6-well fully funded programme
EXCLUSIVE: Rockhopper #RKE tops Malcy's 2018 Interims Bucket List gain


Immupharma Share Price (IMM)



Share Price Information for Immupharma (IMM)


Share Price: 22.30Bid: 21.70Ask: 21.90Change: 0.50 (+2.29%)Riser - Immupharma
Spread: 0.20Spread as %: 0.92%Open: 21.50High: 22.60Low: 21.50Yesterday’s Close: 21.80

Immupharma Plc Ord 10P

Immupharma is listed in the FTSE AIM All-Share
Immupharma is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
22.30
Share Price SpacerBid
21.70
Share Price SpacerAsk
21.90
Share Price SpacerChange
2.29%0.50
Share Price SpacerVolume
318,583
Share Price SpacerOpen
21.50
Share Price SpacerHigh
22.60
Share Price SpacerLow
21.50
Share Price SpacerClose
21.80
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 139.47m £31.10m 10,000

52 Week High 193.00 52 Week High Date 4-JAN-2018
52 Week Low 19.00 52 Week Low Date 17-APR-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
37 110,435 183,148 -4.695 -4.75 0.00 0.00


London South East Users info for Immupharma




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

13-Jul-18
17:08:20
21.80
20,000
Buy* 
21.70
21.90
4,360
Trade Type:
Ordinary

13-Jul-18
16:52:02
21.5852
25,000
Sell* 
21.70
21.90
5,396
Trade Type:
Ordinary

13-Jul-18
16:23:21
21.76
201
Sell* 
21.70
21.90
43.74
Trade Type:
Ordinary




View more Immupharma trades >>

Directors Deals for Immupharma (IMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
30-Apr-15Notification of Holding
Trade Notifier Information for Immupharma
Stephane Robert George Mery held the position of Non-Executive Director at Immupharma at the time of this trade.
 Stephane Robert George Mery
002259
24-Jan-13Sell
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
57GBX62,1690
24-Jan-12Buy
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
80GBX62,1690
View more Immupharma directors dealings >>


halfbutt
Posts: 82
Opinion:No Opinion
Price:21.80
One day
Sun 16:35
10 yrs and - £20k later I'm still here.... looking forward to the next 10yrs... the missus won't let me sell the small holding I have left.... and you know what.... I'm convinced 20p is the bottom....so all the bad news is done... only direction is up from here....
a-2-b
Posts: 1,070
Opinion:No Opinion
Price:21.80
Lupus
Sat 20:42
http://www.foxnews.com/health/2018/07/12/california-woman-denied-manicure-over-lupus-scars-says-ive-never-felt-more-like-leper.html

If only there were a non-immunsupressive treatment like Lupuzor. I can see why they would deny manicure if she was flared up, plus due to the lack of a immune system she could potentially catch anything at the salon if skin was damaged.
Frits
Posts: 690
Premium Chat Member
Opinion:Strong Buy
Price:21.80
Not long till we get positive News
Sat 12:26
Quote from the article -

" Our findings with the therapeutic P140 peptide already used in lupus support the view that down-regulating excessive autophagy could improve patient outcomes by reducing neuronal inflammation"

Not long now till we get positive news that will drive this back to a more realistic share price.

Have a good weekend all.

Frits
begger
Posts: 1,053
Opinion:No Opinion
Price:21.80
imm
Sat 09:55
Looks rather interesting especially where we are at with the sp. Not far off a move i hope. Looks good anyway from here i think.
nomlungu
Posts: 1,532
Opinion:No Opinion
Price:22.30
abc?
Fri 21:06
My mathematical approach to unfolding protein errors made me consider an investment in Abcam.

Any comments from those who have bought products from them would be appreciated...

https://www.abcam.com/pathways/cancer-immunotherapy-immune-checkpoint-pathway
View more share chat for Immupharma (IMM) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.